Company intelligence / Profile preview
Guangzhou Huahai Pharmaceutical
Guangzhou, Guangdong Sheng, Chinahuahaipharm.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Guangzhou Huahai Pharmaceutical is a private Chinese pharmaceutical company focused on the development and commercialization of traditional Chinese medicines and herbal drugs. As of early 2025, it has at least two programs in Phase 2 clinical trials—one for irritable bowel syndrome with diarrhea and another for non-small cell lung cancer—and one pending program for gouty arthritis. The company’s pipeline is primarily based on herbal formulations. There are no published results from pivotal or late-stage clinical trials.
- Therapeutic areas
- GastroenterologyRheumatologyOncology
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Guangzhou Huahai Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Huahai Pharmaceutical.